Ignacio
Matos García
Consultor Médico
Universitat de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat de Barcelona (4)
2019
-
Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials
Expert Opinion on Investigational Drugs, Vol. 28, Núm. 5, pp. 463-471
2018
-
Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer
Expert Opinion on Pharmacotherapy, Vol. 19, Núm. 6, pp. 623-629
-
The safety of ramucirumab for the treatment of colorectal cancer
Expert Opinion on Drug Safety, Vol. 17, Núm. 9, pp. 945-951
2017
-
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
European Journal of Endocrinology, Vol. 177, Núm. 4, pp. 309-317